Peptide aptamers against tenascin C

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9018351
APP PUB NO 20140030736A1
SERIAL NO

13955537

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an anti-tenascin C peptide aptamer having a specific amino acid sequence and a diagnosis kit comprising it. The anti-tenascin C peptide aptamer of the instant invention shows a predominant clearance rate due to its small molecular weight as well as specific binding affinity to tenascin C, having excellent advantages in in vivo or ex vivo tumor imaging.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CDMOGEN CO LTDCHUNGCHEONGBUK-DO 28578

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jeong, Sun Joo Seoul, KR 2 0
Kim, Mee Young Seoul, KR 8 335
Kim, Ok Ran Seoul, KR 2 0
Lee, Heui Ran Seongnam-si, KR 2 0
Park, Kee Rang Cheongju-si, KR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00